Akaza Research Releases OpenClinica 3.0 Electronic Data Capture Software
Waltham, MA
Akaza Research announced the release of OpenClinica 3.0, the newest version of the open source electronic data capture (EDC) software for clinical trials. This latest production release adds a host of new capabilities designed to further accelerate the adoption of open source into mainstream research.
“We have added powerful new capabilities and made them accessible through an intelligent, task-oriented user interface," said Cal Collins, CEO of Akaza Research.
Key features of OpenClinica 3.0 include: streamlined user interface that simplifies site usage, study progress dashboard, improved query workflows, with notifications, chain of custody, and task management, source data verification workspace, faster page load time, dedicated Study Build module, improved control over significant digits in eCRF data items, job scheduler and web services interface to allow for programmatic data interchange with other systems
As open source software, OpenClinica is free for organizations to use and modify. The software may be downloaded here. Akaza Research will be conducting a webinar presentation of OpenClinica 3.0 on October 28, 2009 to demonstrate the new product and answer questions form the community, click here for information.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
